CorMedix

$5.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+1.25%) Today
-$0.15 (-2.65%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CorMedix and other stocks, options, and ETFs commission-free!

About CRMD

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Read More It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ. The listed name for CRMD is CorMedix Inc.

Employees
30
Headquarters
Berkeley Heights, New Jersey
Founded
2006
Market Cap
177.12M
Price-Earnings Ratio
Dividend Yield
Average Volume
234.73K
High Today
$5.75
Low Today
$5.52
Open Price
$5.70
Volume
114.50K
52 Week High
$7.97
52 Week Low
$2.16

Collections

CRMD Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 9, After Hours

You May Also Like